TY - GEN
T1 - Process to discovering iron decrease as chance to use interferon to hepatitis B
AU - Ohsawa, Yukio
AU - Fujie, Hajime
AU - Saiura, Akio
AU - Okazaki, Naoaki
AU - Matsumura, Naohiro
N1 - Funding Information:
Supported by grants from Institut UPSA de la Douleur and Fondation pour la Recherche Medicale (to L.B.). Supported by grants from the Canadian Institute of Health Research, NicOx S.A., and the Canadian Association of Gastroenterology. N.V. is a Canadian Institute of Health Research Scholar.
PY - 2007
Y1 - 2007
N2 - Chance discovery is the process of human interaction with the environment for discovering events significant for making a decision. We executed die double helix process of chance discovery, on the blood-test data for hepatitis B, for obtaining scenarios telling when and how symptoms essential for treatment appear. In the double-helical process of chance discovery, the presented scenario maps are evaluated and fed back to the following cycles, to obtain novel and potentially useful knowledge for treatment. Due to the combination of the objective facts in the data and the subjective focus of the hepatologists' concerns in this process, the relation between the changes of iron quantities due to iron-carrying proteins and the cure of hepatitis B with interferon, has got clarified visually.
AB - Chance discovery is the process of human interaction with the environment for discovering events significant for making a decision. We executed die double helix process of chance discovery, on the blood-test data for hepatitis B, for obtaining scenarios telling when and how symptoms essential for treatment appear. In the double-helical process of chance discovery, the presented scenario maps are evaluated and fed back to the following cycles, to obtain novel and potentially useful knowledge for treatment. Due to the combination of the objective facts in the data and the subjective focus of the hepatologists' concerns in this process, the relation between the changes of iron quantities due to iron-carrying proteins and the cure of hepatitis B with interferon, has got clarified visually.
UR - http://www.scopus.com/inward/record.url?scp=36348983214&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=36348983214&partnerID=8YFLogxK
U2 - 10.1007/978-3-540-71009-7_45
DO - 10.1007/978-3-540-71009-7_45
M3 - Conference contribution
AN - SCOPUS:36348983214
SN - 3540710086
SN - 9783540710080
T3 - Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)
SP - 474
EP - 484
BT - New Frontiers in Artificial Intelligence - JSAI 2003 and JSAI 2004 Conferences and Workshops, Revised Selected Papers
PB - Springer Verlag
T2 - 17th and 18th Annual Conferences of the Japanese Society for Artificial Intelligence, (JSAI 2003 and JSAI 2004)
Y2 - 23 June 2003 through 27 June 2003
ER -
